Zhengzhou Railway Vocational & Technical College, Zhengzhou, China.
Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10879-10884. doi: 10.26355/eurrev_202010_23452.
Among the illnesses that may develop from COVID-19, the disease caused by the novel coronavirus (SARS-CoV-2), is pneumonia, a severe acute respiratory infectious disease. SARS-CoV-2 continues to spread worldwide and has caused hundreds of thousands of deaths thus far and has disrupted the world economy.
This review summarized the reported distributions of SARS-CoV-2 in 13 biological samples of the human body, including nose, feces, sperm, tears, breast milk, cerebrospinal fluid, urine, organs, sputum, cell lines, bronchial brush, blood, throat, and bronchoalveolar lavage fluid. Moreover, this review briefly describes the detection of SARS-CoV-2 in human body samples of five other coronaviruses.
This review offers several recommendations for controlling the spread of SARS-CoV-2 control, specifically, sample collection from suspected cases from foreign countries and risk assessment of imported special goods (biological materials).
在由新型冠状病毒（SARS-CoV-2）引起的 COVID-19 疾病中，肺炎是一种严重的急性呼吸道传染病。SARS-CoV-2 在全球范围内继续传播，迄今为止已造成数十万人死亡，并扰乱了世界经济。
本综述总结了在人体 13 种生物样本中报告的 SARS-CoV-2 分布情况，包括鼻子、粪便、精子、眼泪、母乳、脑脊液、尿液、器官、痰、细胞系、支气管刷、血液、喉咙和支气管肺泡灌洗液。此外，本综述简要描述了另外五种冠状病毒在人体样本中的检测情况。
本综述为控制 SARS-CoV-2 传播提供了一些建议，特别是从国外疑似病例中采集样本，并对进口特殊货物（生物材料）进行风险评估。
